Medicines for biological therapy
- Published
- 13 March 2025
- Submission deadline
- 1 April 2025, 10:00
- Place of performance
- MKZZZ
- Documents
- 1
- Notice number
- 00162848-2025
- Reference
- 3ee7b944-e090-4554-994d-13d7feac9130
- Official source
- Official source
CPV codes
- 33600000Productos farmacéuticos
Description
Medicines for biological therapy
Lots (44)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | L01XE36 Alectinib | 33600000 Productos farmacéuticos | — |
| 2 | L01FF05 Atezolizumab | 33600000 Productos farmacéuticos | — |
| 3 | L01FF05 Atezolizumab | 33600000 Productos farmacéuticos | — |
| 4 | L01EK01 Axitinib | 33600000 Productos farmacéuticos | — |
| 5 | L01XC07 Bevacizumab | 33600000 Productos farmacéuticos | — |
| 6 | L01XC07 Bevacizumab | 33600000 Productos farmacéuticos | — |
| 7 | L01XE38 Cobimetinib | 33600000 Productos farmacéuticos | — |
| 8 | L01XC06 Cetuximab | 33600000 Productos farmacéuticos | — |
| 9 | L01XE03 Erlotinib | 33600000 Productos farmacéuticos | — |
| 10 | L02BA03 Fulvestrant | 33600000 Productos farmacéuticos | — |
| 11 | L01XA03 Oxaliplatin | 33600000 Productos farmacéuticos | — |
| 12 | L01XA03 Oxaliplatin | 33600000 Productos farmacéuticos | — |
| 13 | L01XC18 Pembrolizumab | 33600000 Productos farmacéuticos | — |
| 14 | L01XE11 Pazopanib | 33600000 Productos farmacéuticos | — |
| 15 | L01XE33 Palbociclib | 33600000 Productos farmacéuticos | — |
| 16 | L01XE33 Palbociclib | 33600000 Productos farmacéuticos | — |
| 17 | L01XE33 Palbociclib | 33600000 Productos farmacéuticos | — |
| 18 | L01BA04 Pemetrexed | 33600000 Productos farmacéuticos | — |
| 19 | L01XE42 Ribociclib | 33600000 Productos farmacéuticos | — |
| 20 | L01XE04 Sunitinib | 33600000 Productos farmacéuticos | — |
| 21 | L01XE04 Sunitinib | 33600000 Productos farmacéuticos | — |
| 22 | L01XE05/L01EX02 Sorafenib | 33600000 Productos farmacéuticos | — |
| 23 | L01XC014 Trastuzumab emtansine | 33600000 Productos farmacéuticos | — |
| 24 | L01XC014 Trastuzumab emtansine | 33600000 Productos farmacéuticos | — |
| 25 | L01XY02 Pertuzumab/ trastuzumab | 33600000 Productos farmacéuticos | — |
| 26 | L01XY02 Pertuzumab/ trastuzumab | 33600000 Productos farmacéuticos | — |
| 27 | L02BX03 Abiraterone | 33600000 Productos farmacéuticos | — |
| 28 | L02BX03 Abiraterone | 33600000 Productos farmacéuticos | — |
| 29 | L01XE15 Vemurafenib | 33600000 Productos farmacéuticos | — |
| 30 | L01XE02 Gefitinib | 33600000 Productos farmacéuticos | — |
Official publications
- TED · 00162848-2025 · 13 March 2025
- OJS · 51/2025 · 13 March 2025
Other tenders from University clinic of radiotherapy and oncology
- Full service (regular maintenance and interventional servicing) for therapy machines
- Laboratory reagents and materials
- Procurement of medicines for 2026 Biological therapy
- Drugs that are registered and on the positive list
- Equipment for Brachy therapy
- Procurement of medicines for 2026 Biological therapy
- Laboratory reagents and materials
- Laboratory reagents and materials
- Medicines
- Halcyon MV System Linear Accelerator Service
Frequently asked questions
- What is the deadline to bid for this tender?
- The submission deadline is 1 April 2025, 10:00. Check the official source, as dates can be modified.
- Who is the buyer of this tender?
- The contracting authority is University clinic of radiotherapy and oncology (European Union).
- How can I bid for public tenders in European Union?
- Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.
Create a free account and receive new tenders from European Union matching your business, every day.